Drugs / Thiamine
last change 11 days ago re-read 8 days ago

Thiamine

Other / unclassified

Developed for
infectious disease with sepsis · vitamin deficiency disorder · lactic acidosis · heart failure · HIV infectious disease · obesity disorder · cardiac arrest · coronary artery disorder
+33 more · diabetic polyneuropathy · acute kidney injury · acute respiratory failure · alcohol-related disorders · atrial septal defect · bacterial infectious disease · cardiomyopathy · carpal tunnel syndrome · classic or attenuated familial adenomatous polyposis · congestive heart failure · delirium · diabetic ketoacidosis · heart disorder · Huntington disease · intervertebral disk degenerative disorder · meningitis · migraine with aura · migraine without aura · necrotizing soft tissue infection · patent ductus arteriosus · peripheral neuropathy · pernicious anemia · primary biliary cholangitis · respiratory failure · subarachnoid hemorrhage · uterine disorder · ventricular septal defect · beriberi · COVID-19 · hyperemesis gravidarum · post-cardiac arrest syndrome · thyrotoxicosis · Wernicke-Korsakoff syndrome
Investigated by
Beth Israel Deaconess Medical Center · BREGO Life Sciences Sdn Bhd · Daewoong Pharmaceutical Co. LTD. · Mahidol University · National Heart, Lung, and Blood Institute (NHLBI) · National Institute of Allergy and Infectious Diseases (NIAID)
+89 more · Universitas Sumatera Utara · Aarhus University Hospital · Air Force Specialized Hospital, Cairo, Egypt · American Heart Association · American Medical Association · Andalusian Public Foundation for Health Research in Seville · Ascension Health · Baqiyatallah Medical Sciences University · Baystate Medical Center · Beni-Suef University · Biomedical Research Networking Center (CIBER) · Buck Institute for Research on Aging · CHU de Charleroi · CIHR Canadian HIV Trials Network · Canadian Institutes of Health Research (CIHR) · Centre Hospitalier Universitaire Vaudois · Chengdu University of Traditional Chinese Medicine · Community Medical Center, Toms River, NJ · Corona Doctors Medical Clinics, Inc. · Emory University · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) · Faculdade de Medicina do ABC · Far Eastern Memorial Hospital · French National Institute of Health and Medical Research · Fresenius Kabi · Fundação Educacional Serra dos Órgãos · GCP-unit at Aarhus University Hospital, Aarhus, Denmark · GlaxoSmithKline · Hamad Medical Corporation · Hamadan University of Medical Science · Hamilton Health Sciences Corporation · Henning Grønbæk · Hoskinson Health and Wellness Clinic · Hospital Sirio-Libanes · Hospital Universitario Dr. Jose E. Gonzalez · Hospitalsapoteket Region Midtjylland · Infectious Diseases Institute, Uganda · Liverpool School of Tropical Medicine · Loma Linda University · Mashhad University of Medical Sciences · Medical University of Vienna · Merck KGaA, Darmstadt, Germany · Merck S.A. de C.V., Mexico · Michael Donnino · Milton S. Hershey Medical Center · Ministry of Health, Brazil · Mohamed Mohi El deen Abo El yazeed · Mostafa Ismail Sharaf · National Center for Complementary and Integrative Health (NCCIH) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · National Institute on Aging (NIA) · National Institutes of Health (NIH) · National Research Foundation of Korea · New York Presbyterian Brooklyn Methodist Hospital · Northern Jiangsu People's Hospital · Ontario HIV Treatment Network · Open Philanthropy · PROADI-SUS · Phoenix VA Health Care System · Population Health Research Institute · Queen's University · Region Hovedstadens Apotek · Rising Tide Foundation · Salah Eldeen Ibrahim Alsherif · Sarah Saxena · Shanghai Zhongshan Hospital · Southeast University, China · Tae Gun Shin · Tanta University · Tehran University of Medical Sciences · The Cleveland Clinic · The Marcus Foundation · Trinity Health Of New England · UNC Lineberger Comprehensive Cancer Center · all 95 on the full record

Regulatory milestones approvals, filings & regulatory actions · 1 recorded

MilestoneJurisdictionBrandIndicationDateSentence it was read from
Approved US (FDA) BEROCCA PN — 1947-07-28 fda.gov ↗

Trials 65 · started per year

today
US approved 1947
1
1
2
1
1
3
2
2
2
2
2
1
6
9
9
1
5
1
4
6
3
1946194719481949195019511952195319541955195619571958195919601961196219631964196519661967196819691970197119721973197419751976197719781979198019811982198319841985198619871988198919901991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027202820292030
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 03 trials
Phase 0 NCT06326996 Oct 2024 → Jun 2026 overdue coronary artery disorder University of California, Los Angeles Recruiting No outcome recorded
Phase 0 NCT06298344 May 2024 → Dec 2025 atrial septal defect, patent ductus arteriosus, ventricular septal defect, vitamin deficiency disorder Universitas Sumatera Utara Completed No outcome recorded
Phase 0 NCT06242535 Jul 2023 → May 2024 cognitive disorder, depressive disorder, hyperlipidemia, hypertensive disorder +1 Hoskinson Health and Wellness Clinic Completed No outcome recorded
Phase 12 trials
Phase 1 NCT03122678 Nov 2016 → Mar 2019 infectious disease with sepsis, lactic acidosis, vitamin deficiency disorder The Cleveland Clinic Withdrawn No outcome recorded Stop: Enrollment
Phase 1 NCT02054299 Apr 2013 → Feb 2016 — University Medical Center Goettingen Completed No outcome recorded
Phase 1/24 trials · 1 missed
Phase 1/2 NCT05083546 Dec 2024 → Dec 2025 obesity disorder University of California, San Francisco Withdrawn No outcome recorded Stop: Business
Phase 1/2 NCT05157360 Sep 2021 → May 2023 infectious disease with sepsis, necrotizing soft tissue infection Ascension Health Terminated No outcome recorded Stop: Enrollment
Phase 1/2 NCT03220113 Jul 2017 → Jul 2018 migraine with aura, migraine without aura Corona Doctors Medical Clinics, Inc. Unknown No outcome recorded
Phase 1/2 NCT01070810 Feb 2010 → Nov 2014 infectious disease with sepsis Beth Israel Deaconess Medical Center Completed Missed primary
Phase 217 trials · 1 met primary · 7 missed
Phase 2 NCT07868679 Dec 2026 → Nov 2031 expected bacterial infectious disease, meningitis Milton S. Hershey Medical Center Not yet recruiting No outcome recorded
Phase 2 NCT07844720 Oct 2026 → Oct 2027 expected alcohol-related disorders French National Institute of Health and Medical Research Not yet recruiting No outcome recorded
Phase 2 NCT06568185 May → Oct 2024 overdue diabetic polyneuropathy Universiti Sains Malaysia Recruiting No outcome recorded
Phase 2 NCT04478734 Apr 2023 → Jun 2025 overdue Huntington disease Andalusian Public Foundation for Health Research in Seville Recruiting No outcome recorded
Phase 2 NCT04999137 Sep → Dec 2021 HIV infectious disease, infectious disease with sepsis Liverpool School of Tropical Medicine Unknown No outcome recorded
Phase 2 NCT03756220 Dec 2018 → Jan 2020 infectious disease with sepsis Tae Gun Shin Completed No outcome recorded
Phase 2 NCT03717896 Nov 2018 → Sep 2024 diabetic ketoacidosis Beth Israel Deaconess Medical Center Completed No outcome recorded
Phase 2 NCT03592277 Sep 2018 → Feb 2021 infectious disease with sepsis Trinity Health Of New England Completed Missed primary
Phase 2 NCT03550794 Sep 2018 → Apr 2022 acute kidney injury, infectious disease with sepsis, vitamin deficiency disorder Beth Israel Deaconess Medical Center Completed Missed primary
Phase 2 NCT03450707 May 2018 → Feb 2022 cardiac arrest Michael Donnino Terminated Missed primary
Phase 2/34 trials · 2 missed
Phase 2/3 NCT06940557 Dec 2023 → Sep 2024 carpal tunnel syndrome Universiti Putra Malaysia Completed No outcome recorded
Phase 2/3 NCT03380507 Mar 2018 → Oct 2019 infectious disease with sepsis Hamad Medical Corporation Terminated Missed primary Stop: Business
Phase 2/3 NCT03389555 Feb 2018 → Nov 2019 infectious disease with sepsis, metabolic disease Beth Israel Deaconess Medical Center Completed Missed primary
Phase 2/3 NCT00143702 Aug 2001 → Aug 2006 lactic acidosis University of British Columbia Completed No outcome recorded
Phase 311 trials · 3 missed
Phase 3 NCT05873881 Jan 2024 → Jun 2027 expected heart failure Hamilton Health Sciences Corporation Recruiting No outcome recorded
Phase 3 NCT05971680 Jul → Nov 2023 uterine disorder Beni-Suef University Unknown No outcome recorded
Phase 3 NCT05192213 Aug 2021 → Jul 2022 infectious disease with sepsis Hospital Sirio-Libanes Terminated No outcome recorded Stop: Enrollment
Phase 3 NCT04134403 Dec 2019 → Nov 2020 infectious disease with sepsis Baqiyatallah Medical Sciences University Unknown No outcome recorded
Phase 3 NCT03828929 Oct 2019 → Jan 2020 infectious disease with sepsis New York Presbyterian Brooklyn Methodist Hospital Terminated No outcome recorded
Phase 3 NCT04508946 Aug 2019 → Nov 2020 infectious disease with sepsis Air Force Specialized Hospital, Cairo, Egypt Completed No outcome recorded
Phase 3 NCT03989700 Jul 2019 → Jun 2020 heart disorder Mahidol University Unknown Missed primary
Phase 3 NCT03872011 Feb 2019 → Sep 2021 infectious disease with sepsis Northern Jiangsu People's Hospital Completed Missed primary
Phase 3 NCT03509350 Aug 2018 → Aug 2019 infectious disease with sepsis Emory University Completed Missed primary
Phase 3 NCT01115504 May → Nov 2010 heart failure Mashhad University of Medical Sciences Completed No outcome recorded
Phase 414 trials · 1 met primary · 3 missed
Phase 4 NCT07592897 Jun → Nov 2026 expected — University of Sao Paulo Not yet recruiting No outcome recorded
Phase 4 NCT05221892 Nov 2021 → Mar 2023 — Fundação Educacional Serra dos Órgãos Completed No outcome recorded
Phase 4 NCT04893993 May 2021 → Dec 2022 primary biliary cholangitis Henning Grønbæk Unknown Missed primary
Phase 4 NCT04641104 Nov 2020 → Oct 2022 lactic acidosis, vitamin deficiency disorder Sarah Saxena Completed Missed primary
Phase 4 NCT04039815 Dec 2019 → Dec 2020 infectious disease with sepsis Far Eastern Memorial Hospital Unknown No outcome recorded
Phase 4 NCT06152458 Jan 2019 → Mar 2020 infectious disease with sepsis University of Pecs Completed No outcome recorded
Phase 4 NCT03372447 Dec 2017 → Dec 2018 pernicious anemia Hospital Universitario Dr. Jose E. Gonzalez Completed No outcome recorded
Phase 4 NCT03335124 Sep 2017 → Dec 2018 infectious disease with sepsis University Medical Centre Ljubljana Terminated No outcome recorded Stop: Enrollment
Phase 4 NCT02464865 Aug 2015 → Jul 2018 obesity disorder, vitamin deficiency disorder Mahidol University Completed No outcome recorded
Phase 4 NCT02418130 Oct 2014 → Mar 2015 — Daewoong Pharmaceutical Co. LTD. Completed No outcome recorded
Phase not applicable10 trials
— NCT06649825 Jan 2024 → Apr 2028 expected classic or attenuated familial adenomatous polyposis Shanghai Zhongshan Hospital Enrolling by invitation No outcome recorded
— NCT05663164 Oct → Nov 2022 infectious disease with sepsis, vitamin deficiency disorder Universitas Sumatera Utara Completed No outcome recorded
— NCT04160676 Dec 2019 → Jul 2021 infectious disease with sepsis Tanta University Completed No outcome recorded
— NCT03821714 Feb 2019 → Jan 2020 infectious disease with sepsis Southeast University, China Completed No outcome recorded
— NCT02087462 Jan 2012 → Apr 2014 intervertebral disk degenerative disorder Chengdu University of Traditional Chinese Medicine Unknown No outcome recorded
— NCT01462279 Sep 2011 → Oct 2012 acute respiratory failure Beth Israel Deaconess Medical Center Completed No outcome recorded
— NCT01474486 Apr 2010 → Feb 2016 cardiomyopathy, congestive heart failure Phoenix VA Health Care System Completed No outcome recorded
— NCT00279266 Jan → Jun 2006 diabetes mellitus, peripheral neuropathy Loma Linda University Withdrawn No outcome recorded Stop: Enrollment
— NCT00037063 — HIV infectious disease National Institute of Allergy and Infectious Diseases (NIAID) Withdrawn No outcome recorded
— NCT00031057 ? → Mar 2003 HIV infectious disease National Institute of Allergy and Infectious Diseases (NIAID) Completed No outcome recorded
Comparator or background therapy22 trials
Phase 1 NCT05027126 Background Feb → Nov 2019 — Laboratorios Silanes S.A. de C.V. Completed No outcome recorded
Phase 1 NCT01864057 Comparator Jan → Jul 2012 beriberi Mayo Clinic Completed No outcome recorded
Phase 1/2 NCT04708340 Comparator Mar 2021 → Oct 2022 COVID-19, acute respiratory distress syndrome Reven Pharmaceuticals, Inc. Unknown No outcome recorded
Phase 2 NCT05817851 Background Dec 2023 → Dec 2027 expected cardiac arrest Centre Hospitalier de Bethune Recruiting No outcome recorded
Phase 2 NCT04921189 Comparator Dec 2021 → Dec 2024 cardiac arrest, post-cardiac arrest syndrome Asan Medical Center Completed No outcome recorded

News releases announcing trial results or a regulatory action · 1

DateIssuerRelease
2020-05-20 KRKA Regulatory Krka Reports First Quarter 2020 Business Results krka.biz ↗
We extended our range of non-prescription products with a marketing authorisation for our new formulation of B-complex (thiamine/riboflavin/pyridoxine/cyanocobalamin/calcium pantothenate/nicotinamide) film-coated tablets.

All press releases naming this drug 1 release

DateIssuerRelease

Evidence & citations 14 cited values

Every value below carries the sentence it was read from. 88 sources stand behind the page.

FieldValueCited text
Known as thiamine “Active drug comprised of: ascorbic acid, magnesium sulfate heptahydrate, cyanocobalamin, thiamine, riboflavin 5' phosphate, niacinamide, pyridoxine, calcium d-pantothenate, and...” NCT04708340 ↗
65

“Each tablet contains 4 active ingredients as follows: Alpha lipoic acid 300mg, Vitamin B12 (methylcobalamin) 500mcg, Vitamin B6 (pyridoxine) 8mg, Vitamin B1 (thiamine) 39mg.” NCT06568185 ↗

“gabapentin (GBP) plus complex B vitamins: thiamine (B1) and cyanocobalamine (B12) compared to pregabalin in patients with moderate to severe intensity PDN.” PMID 26885528 ↗ Jan 2016

“intravenous Thiamine (200mg in 50 mL of 0.9% normal saline and was administered as a 30-min infusion every 12 hours for 4 days or until ICU discharge)” NCT04039815 ↗

“and thiamine (200 mg every 12 hours administered as an infusion over 30 to 60 minutes and mixed in a 100-mL solution of normal saline) for 3 days.” NCT06152458 ↗

“Complex B ((Thiamine 100mg, Pyridoxine 5 mg and Cyanocobalamin 50 mcg) 1 tablet enteral route every 6 horas for 4 days or until ICU discharge” NCT04197115 ↗

“Patients were assigned randomly to receive thiamine (300 mg in 0.9% Normal saline solution) or placebo (0.9% Normal saline) preoperatively.” PMID 26066773 ↗ Aug 2015

“receiving intravenous Vitamin C (1.5 g every 6 hours), Thiamine (200 mg every 12 hours) and Hydrocortisone (50 mg every 6 hours) for 7 days” NCT05192213 ↗

“In addition, all patients will receive intravenous thiamine 200 mg twice a day for 3 days to limit the oxalate production.” NCT05817851 ↗

“Dosage: 25 mg of Dexketoprofen + Cyanocobalamin 500 µg, Thiamine 100 mg, Pyridoxine 50 mg. Administration way: oral” NCT05027126 ↗

“MGO cocktail containing a combination of alpha-lipoic acid, nicotinamide, thiamine, pyridoxamine, and piperine” NCT05083546 ↗

Show 55 more sources

Known as Bevitine “Vitamin C (Laroscorbine) + Vitamin B1 (Bevitine)” NCT05817851 ↗
Known as Thiamin “Thiamine (vitamin B1) is a water-soluble vitamin and is involved in several stages of intermediate metabolism which are important for producing energy.” NCT01524315 ↗
3

“Thiamin one tablet daily provides 50 milligrams(mg) of thiamin, Vitamin B-50 one tablet daily: provides an additional 50 mg of thiamin” NCT01474486 ↗

NCT03989700 ↗

NCT03372447 ↗

Known as Thiamine HNO3 “Vitamin B1 (Thiamine HNO3): 1.5 mg” NCT00064753 ↗
Known as Thiamine hydrochloride “Thiamine hydrochloride (vitamin B1) 500mg IV will be given every 12 hours for 5 doses in the experimental arm.” NCT03450707 ↗
2

NCT02788552 ↗

NCT00037063 ↗

Known as Thiamine Hydrocloride “Patients in this arm will receive a solution of 500 mg of Thiamine Hydrocloride in a solution of 100 ml of NaCl 0.9%.” NCT04641104 ↗
Known as Thiamine Mononitrate “Thiamine (thiamine mononitrate) - 10 mg” NCT07592897 ↗
1

“Drug: Thiamine Mononitrate” NCT03989700 ↗

Known as Thiamine: brand name: Thiamine Hakim “Thiamine: brand name: Thiamine Hakim” NCT01115504 ↗
Known as Vitamin B1 “A small retrospective study demonstrated a mortality benefit by using high dose vitamin C, thiamine (vitamin B1), and hydrocortisone (Triple therapy) for treatment of septic...” NCT04508946 ↗
26

“Thiamine (Vitamin B1) is essential for cell function and as a co-factor of the enzyme Pyruvate Dehydrogenase to initiate the Krebs cycle and thus the aerobic metabolism of glucose.” NCT04641104 ↗

“Deficiencies in thiamine (vitamin B1) and riboflavin (vitamin B2) have been implicated as cofactors in producing hyperlactatemia and lactic acidosis in NRTI-treated patients.” NCT00031057 ↗

“Each tablet contains 4 active ingredients as follows: Alpha lipoic acid 300mg, Vitamin B12 (methylcobalamin) 500mcg, Vitamin B6 (pyridoxine) 8mg, Vitamin B1 (thiamine) 39mg.” NCT06568185 ↗

“Each capsule is a combination of vitamins and natural products: Vitamin B1 (100mg); Vitamin B6 (50mg); Niacin (200mg); Alpha Lipoic Acid (150mg); and Piperine (15mg).” NCT06242535 ↗

“Thiamine (vitamin B1) is a water-soluble vitamin and is involved in several stages of intermediate metabolism which are important for producing energy.” NCT01524315 ↗

“This study will examine the effect of oral thiamine (Vitamin B1) supplementation on pain in patients with diabetic peripheral neuropathy.” NCT00279266 ↗

“vitamin B1 (100mg) will be diluted in 50 ml 0.9% NACL(normal saline) and administered IV every 6 hours for 3 days” NCT05663164 ↗

“Glucocorticoid combination therapy is defined as the combination of hydrocortisone, vitamin C, and vitamin B1.” NCT03821714 ↗

“Supplementation of thiamine (vitamin b1) 300 mg per day, once daily, for a duration of 4 weeks” NCT00770107 ↗

“hydrocortisone, ascorbic acid (vitamin C), and thiamine (vitamin B1); referred to as HAT” NCT05157360 ↗

Show 16 more sources

Known as Vitamin B1 or Thiamin or Thiamine or Aneurin “Vitamin B1 or Thiamin or Thiamine or Aneurin” NCT02087462 ↗
Known as Vitamin B1-injektopas “thiamine (Vitamin B1-injektopas®, Ampoule, Germany, 100 mg / 2 ml) 200 mg diluted in 10 ml normal saline IV /12 h” NCT04160676 ↗
Action Activate “Thiamine (vitamin B1) is a key co-factor for PDH function and will increase activity even in non-deficient states.” NCT02322892 ↗
Modality Other / unclassified “combination of AOX micronutrient supplements” NCT00515736 ↗
Route Oral “every patient receives high-dose oral vitamin B1 and B2 therapy for 4 weeks.” NCT00031057 ↗